MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

logo_teva-svg

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

logo_teva-svg

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

|||

Balance Sheets Overview

Current Ratio
87.95%
Quick Ratio
67.36%
Cash Ratio
23.36%
Debt to Asset Ratio
80.54%
Unit: Million (M) dollars
Assets Breakdown
    • Goodwill
    • Accumulated amortization
    • Property, plant and equipment, n...
    • Others
Liabilities Breakdown
    • Additionalpaid-incapital
    • Accumulated deficit
    • Senior notes and loans
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
3,655
3,741
3,556
2,203
Accounts receivables, net of allowance for credit losses of 75 million and 81 million as of june 30, 2026 and december 31, 2025, respectively
3,493
3,393
3,709
3,810
Inventories
3,221
3,176
3,179
3,323
Prepaid expenses
1,034
1,070
1,122
1,115
Other current assets
563
535
539
477
Assets held for sale
1,794
1,794
1,842
1,809
Total current assets
13,760
13,710
13,946
12,736
Deferred income taxes
2,162
2,190
2,191
1,634
Othernon-currentassets
387
377
405
444
Property, plant and equipment, net
3,928
3,998
4,080
4,820
Operating lease right-of-use assets, net
333
335
345
342
Accumulated amortization
-
0
0
0
Gross carrying amount net of impairment
16,923
16,966
17,111
17,139
Accumulated amortization
13,476
13,357
13,330
13,203
Identifiable intangible assets, net
3,447
3,609
3,781
3,936
Goodwill
15,839
15,822
16,000
15,945
Total assets
39,857
40,040
40,748
39,856
Short-term debt
4,500
2,612
1,820
24
Sales reserves and allowances
3,899
3,707
4,143
4,134
Accounts payables
2,721
2,596
2,531
2,355
Employee-related obligations
488
555
739
561
Accrued expenses
2,738
2,616
2,687
2,989
Other current liabilities
987
1,111
1,182
1,103
Liabilities held for sale
313
334
354
324
Total current liabilities
15,646
13,532
13,456
11,491
Deferred income taxes
289
273
296
399
Other taxes and long-term liabilities
3,791
3,709
3,808
3,664
Senior notes and loans
12,092
14,015
14,986
16,766
Operating lease liabilities
282
280
288
283
Total long-term liabilities
16,454
18,277
19,379
21,111
Total liabilities
32,100
31,809
32,834
32,602
Redeemable non-controlling interests
-
-
-
0
Ordinary shares of nis 0.10 par value per share june30, 2026 and december31, 2025 authorized 2,495million shares issued 1,271million shares and 1,257million shares, respectively
59
59
58
58
Additionalpaid-incapital
28,256
28,203
28,133
28,038
Accumulated deficit
-13,969
-13,394
-13,762
-14,243
Accumulated other comprehensive loss
-2,465
-2,512
-2,391
-2,475
Treasury shares as of june30, 2026 and december31, 2025 106million ordinary shares and 107million ordinary shares, respectively
4,128
4,128
4,128
4,128
Stockholders' equity attributable to teva shareholders
7,753
8,228
7,910
7,250
Non-controlling interests
4
4
4
4
Total equity
7,757
8,232
7,914
7,254
Total liabilities and equity
39,857
40,040
40,748
39,856
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$3,655M (69.13%↑ Y/Y)Accounts receivables,net of allowance for...$3,493M (-1.99%↓ Y/Y)Inventories$3,221M (-7.89%↓ Y/Y)Assets held for sale$1,794M (-2.61%↓ Y/Y)Prepaid expenses$1,034M (-4.61%↓ Y/Y)Other current assets$563M (19.28%↑ Y/Y)Gross carrying amountnet of impairment$16,923M (-1.65%↓ Y/Y)Goodwill$15,839M (-0.69%↓ Y/Y)Total current assets$13,760M (9.03%↑ Y/Y)Property, plant andequipment, net$3,928M (-18.34%↓ Y/Y)Identifiable intangibleassets, net$3,447M (-16.78%↓ Y/Y)Deferred income taxes$2,162M (21.39%↑ Y/Y)Othernon-currentassets$387M (-17.66%↓ Y/Y)Operating leaseright-of-use assets, net$333M (-6.98%↓ Y/Y)Accumulated amortization$13,476M (3.15%↑ Y/Y)Total assets$39,857M (-0.68%↓ Y/Y)Total liabilities andequity$39,857M (-0.68%↓ Y/Y)Total liabilities$32,100M (-3.59%↓ Y/Y)Total equity$7,757M (13.51%↑ Y/Y)Total long-termliabilities$16,454M (-23.24%↓ Y/Y)Total currentliabilities$15,646M (31.91%↑ Y/Y)Stockholders' equityattributable to teva...$7,753M (13.56%↑ Y/Y)Non-controlling interests$4M (-42.86%↓ Y/Y)Accumulated deficit-$13,969M (4.82%↑ Y/Y)Treasury shares as ofjune30, 2026 and...$4,128M (0.00%↑ Y/Y)Accumulated othercomprehensive loss-$2,465M (-1.40%↓ Y/Y)Senior notes and loans$12,092M (-27.86%↓ Y/Y)Other taxes andlong-term liabilities$3,791M (-3.73%↓ Y/Y)Deferred income taxes$289M (-34.32%↓ Y/Y)Operating leaseliabilities$282M (-4.73%↓ Y/Y)Short-term debt$4,500M (869.83%↑ Y/Y)Sales reserves andallowances$3,899M (-3.73%↓ Y/Y)Accrued expenses$2,738M (-11.53%↓ Y/Y)Accounts payables$2,721M (8.93%↑ Y/Y)Other currentliabilities$987M (5.00%↑ Y/Y)Employee-related obligations$488M (1.46%↑ Y/Y)Liabilities held for sale$313M (-6.29%↓ Y/Y)Additionalpaid-incapital$28,256M (0.90%↑ Y/Y)Ordinary shares of nis0.10 par value per...$59M (1.72%↑ Y/Y)
🚨 Price Alert: The stock price jumped by 10.72% after the earning call.